Barrow Hanley Mewhinney & Strauss LLC Has $431.16 Million Stock Holdings in Avantor, Inc. $AVTR

Barrow Hanley Mewhinney & Strauss LLC grew its holdings in Avantor, Inc. (NYSE:AVTR) by 10.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 34,548,129 shares of the company’s stock after purchasing an additional 3,356,861 shares during the quarter. Avantor makes up approximately 1.4% of Barrow Hanley Mewhinney & Strauss LLC’s holdings, making the stock its 25th biggest holding. Barrow Hanley Mewhinney & Strauss LLC owned about 5.07% of Avantor worth $431,161,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Sector Gamma AS increased its holdings in Avantor by 28.0% in the third quarter. Sector Gamma AS now owns 477,104 shares of the company’s stock valued at $5,954,000 after purchasing an additional 104,466 shares during the last quarter. Greenhaven Associates Inc. bought a new position in Avantor during the third quarter worth about $228,528,000. Quantbot Technologies LP boosted its holdings in Avantor by 1,333.0% during the third quarter. Quantbot Technologies LP now owns 246,494 shares of the company’s stock worth $3,076,000 after buying an additional 229,293 shares during the last quarter. Voss Capital LP acquired a new position in shares of Avantor during the 2nd quarter worth about $6,057,000. Finally, ABS Direct Equity Fund LLC bought a new stake in shares of Avantor in the 3rd quarter valued at about $1,248,000. 95.08% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on AVTR. Citigroup cut their price target on shares of Avantor from $13.00 to $11.00 and set a “neutral” rating on the stock in a research report on Thursday, February 12th. Robert W. Baird set a $11.00 target price on shares of Avantor in a research note on Thursday, February 12th. Zacks Research lowered shares of Avantor from a “hold” rating to a “strong sell” rating in a report on Friday, February 13th. Barclays reissued an “underweight” rating and set a $8.50 price target on shares of Avantor in a research report on Friday, March 6th. Finally, Bank of America cut shares of Avantor from a “buy” rating to a “neutral” rating and set a $13.00 price objective for the company. in a research report on Monday, December 15th. Three analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $11.80.

Avantor Stock Performance

AVTR opened at $8.16 on Wednesday. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. Avantor, Inc. has a 12-month low of $7.82 and a 12-month high of $17.29. The business has a 50 day moving average of $10.57 and a 200-day moving average of $11.77. The stock has a market cap of $5.56 billion, a price-to-earnings ratio of -10.46, a PEG ratio of 3.20 and a beta of 0.97.

Avantor (NYSE:AVTR) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. The business had revenue of $1.66 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Avantor had a positive return on equity of 10.45% and a negative net margin of 8.09%.The firm’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.27 EPS. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. On average, equities research analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current year.

Insider Transactions at Avantor

In related news, Director Gregory T. Lucier bought 50,000 shares of Avantor stock in a transaction dated Thursday, February 19th. The shares were bought at an average cost of $9.16 per share, with a total value of $458,000.00. Following the acquisition, the director owned 50,000 shares in the company, valued at $458,000. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Gregory L. Summe bought 100,000 shares of the firm’s stock in a transaction on Thursday, February 12th. The stock was purchased at an average cost of $9.40 per share, for a total transaction of $940,000.00. Following the completion of the acquisition, the director owned 400,000 shares in the company, valued at approximately $3,760,000. This trade represents a 33.33% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 1.20% of the stock is currently owned by company insiders.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.